loadpatents
name:-0.023925065994263
name:-0.011553049087524
name:-0.0063889026641846
SCHALL; Thomas Patent Filings

SCHALL; Thomas

Patent Applications and Registrations

Patent applications and USPTO patent grants for SCHALL; Thomas.The latest application filed is for "method of treating focal segmental glomerulosclerosis".

Company Profile
6.12.21
  • SCHALL; Thomas - San Carlos CA
  • Schall; Thomas - Mountain View CA
  • Schall; Thomas - Palo Alto CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Method Of Treating Focal Segmental Glomerulosclerosis
App 20220226294 - MIAO; Zhenhua ;   et al.
2022-07-21
Method of Treating Focal Segmental Glomerulosclerosis
Grant 11,324,736 - Miao , et al. May 10, 2
2022-05-10
Compositions And Methods For Treating Inflammatory Bowel Disease Using A Combination Therapy Of Small Molecule Inhibitors Of C-c Chemokine Receptor Type 9 (ccr9) And Anti-alpha4beta7 Integrin Blocking Antibodies
App 20210322410 - CAMPBELL; James ;   et al.
2021-10-21
Compositions And Methods For Treating Inflammatory Bowel Disease Using Ccr9 Inhibitor And Anti-il-23 Blocking Antibodies
App 20210308119 - CAMPBELL; James ;   et al.
2021-10-07
Compositions and methods for treating inflammatory bowel disease using a combination therapy of small molecule inhibitors of C-C chemokine receptor type 9 (CCR9) and anti-.alpha.4.beta.7 integrin blocking antibodies
Grant 11,045,469 - Campbell , et al. June 29, 2
2021-06-29
Compositions and methods for treating inflammatory bowel disease using a combination therapy of small molecule inhibitors of C--C chemokine receptor type 9 (CCR9) and anti-.alpha.4.beta.7 integrin blocking antibodies
Grant 11,020,394 - Zeng , et al. June 1, 2
2021-06-01
Compositions and Methods for Treating CCR9-Mediated Diseases using CCR9 Inhibitor and Anti-TNF-Alpha Blocking Antibodies
App 20210154292 - SCHALL; Thomas ;   et al.
2021-05-27
Method of treating focal segmental glomerulosclerosis
Grant 10,973,809 - Miao , et al. April 13, 2
2021-04-13
Method of Treating Focal Segmental Glomerulosclerosis
App 20200323832 - MIAO; Zhenhua ;   et al.
2020-10-15
Compositions and methods for treating inflammatory bowel disease using CCR9 inhibitor and anti-TNF-alpha blocking antibodies
Grant 10,792,360 - Schall , et al. October 6, 2
2020-10-06
Compositions And Methods For Treating Inflammatory Bowel Disease Using A Combination Therapy Of Small Molecule Inhibitors Of C-c
App 20200268751 - Campbell; James ;   et al.
2020-08-27
Method Of Treating Focal Segmental Glomerulosclerosis
App 20180140587 - Miao; Zhenhua ;   et al.
2018-05-24
Bis-aryl sulfonamides
Grant 8,642,808 - Ungashe , et al. February 4, 2
2014-02-04
Bis-aryl Sulfonamides
App 20110257183 - Ungashe; Solomon ;   et al.
2011-10-20
Reagents That Bind Ccx-ckr2
App 20100278820 - Howard; Maureen ;   et al.
2010-11-04
Methods and Compositions For Modulating Angiogenesis
App 20100247540 - Burns; Jennifer ;   et al.
2010-09-30
Bis-aryl Sulfonamides
App 20100227902 - Ungashe; Solomon ;   et al.
2010-09-09
Bis-aryl sulfonamides
Grant 7,741,519 - Ungashe , et al. June 22, 2
2010-06-22
Inhibitors Of Human Tumor-expressed Ccxckr2
App 20100144720 - Melikian; Anita ;   et al.
2010-06-10
Antibodies that bind CCX-CKR2
Grant 7,678,891 - Howard , et al. March 16, 2
2010-03-16
Inhibitors of human tumor-expressed CCXCKR2
Grant 7,649,011 - Melikian , et al. January 19, 2
2010-01-19
Bis-aryl Sulfonamides
App 20080261966 - Ungashe; Solomon ;   et al.
2008-10-23
Bis-aryl sulfonamides
Grant 7,335,653 - Ungashe , et al. February 26, 2
2008-02-26
Bis-aryl sulfonamides
App 20070203131 - Ungashe; Solomon ;   et al.
2007-08-30
Bis-aryl sulfonamides
Grant 7,227,035 - Ungashe , et al. June 5, 2
2007-06-05
Reagents that bind CCX-CKR2
App 20060257410 - Howard; Maureen ;   et al.
2006-11-16
Compositions and methods of use of W-peptides
App 20050234004 - Premack, Brett ;   et al.
2005-10-20
Methods and compositions for modulating angiogenesis
App 20050214287 - Burns, Jennifer ;   et al.
2005-09-29
Cell proliferation associated with CCX CKR expression
App 20050176073 - Wang, Yu ;   et al.
2005-08-11
Bis-aryl sulfonamides
App 20050137179 - Ungashe, Solomon ;   et al.
2005-06-23
Inhibitors of human tumor-expressed CCXCKR2
App 20040171655 - Melikian, Anita ;   et al.
2004-09-02
Bis-aryl sulfonamides
App 20040167113 - Ugashe, Solomon ;   et al.
2004-08-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed